CANOPY GROWTH CORPORATION ORDINARY SHARE (OTCMKTS:TWMJF) Just Reported Increased Shorts

June 13, 2018 - By Stephen Andrade

Canopy Growth Corporation (OTCMKTS:TWMJF) Logo

The stock of CANOPY GROWTH CORPORATION ORDINARY SHARE (OTCMKTS:TWMJF) registered an increase of 0.61% in short interest. TWMJF’s total short interest was 13.38 million shares in June as published by FINRA. Its up 0.61% from 13.30 million shares, reported previously. With 1.16 million shares average volume, it will take short sellers 12 days to cover their TWMJF’s short positions. The short interest to CANOPY GROWTH CORPORATION ORDINARY SHARE’s float is 8.06%.

It closed at $30.2137 lastly. It is down 0.00% since June 13, 2017 and is . It has underperformed by 12.57% the S&P500.

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company has market cap of $6.01 billion. The firm offers dried, oil, and softgel cannabis products. It currently has negative earnings. Canopy Growth Corporation also sells its products through online.

More notable recent Canopy Growth Corporation (OTCMKTS:TWMJF) news were published by: Profitconfidential.com which released: “Marijuana News Today: Aurora-MedReleaf Acquisition, Canopy Stock Listing on NYSE” on May 16, 2018, also Profitconfidential.com with their article: “Marijuana Stocks: Why I Would Choose Aurora Stock at Any Point in Time” published on May 28, 2018, Profitconfidential.com published: “Marijuana News Today: Could New York Recreational Marijuana Legalization Be on the Way?” on May 22, 2018. More interesting news about Canopy Growth Corporation (OTCMKTS:TWMJF) were released by: Midasletter.com and their article: “Two Interesting Charts For Tomorrow: Hydropothecary, Canopy Growth Corp” published on May 25, 2018 as well as Profitconfidential.com‘s news article titled: “CGC Stock: Canopy Growth to List on NYSE, Enter US Market Before June” with publication date: May 16, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.